Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 44,830 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 13.23 | Mínimo Máximo |
|||||
| Minimo del Dia | 10.98 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Avalo Therapeutics Inc | AVTX | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 1.95 | 17.49% | 13.10 | 23:00:07 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 10.98 | 10.98 | 13.23 | 13.10 | 11.15 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 818 | 44,830 | US$ 12.07 | US$ 541,223 | - | 3.9501 - 1,130.40 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:44:17 | 99 | US$ 12.14 | USD |
Información Financiera Avalo Therapeutics Inc AVTX
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 2.35M | 801.61k | - | 1.92M | -31.54M | -39.35 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Avalo Therapeutics Inc AVTX
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 23/5/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 11:38 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 13/5/2024 | 06:33 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 06:30 | GlobeNewswire Inc. | Avalo Reports First Quarter 2024 Financial Results and.. |
| 02/4/2024 | 06:00 | GlobeNewswire Inc. | Avalo Therapeutics Appoints Biotech Leaders to Board of.. |
| 29/3/2024 | 15:01 | GlobeNewswire Inc. | Avalo Reports 2023 Financial Results and Provides Business.. |
| 27/3/2024 | 15:01 | GlobeNewswire Inc. | Avalo Acquires Anti-IL-1β mAb and Announces Private.. |
| 14/2/2024 | 20:13 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 14/2/2024 | 09:02 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 31/1/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/12/2023 | 16:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos AVTX
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.64 | 13.23 | 8.9174 | 10.52 | 35,204 | 3.46 | 35.89% |
| 1 Month | 15.00 | 17.49 | 8.9174 | 12.91 | 54,090 | -1.90 | -12.67% |
| 3 Months | 4.37 | 34.46 | 4.3039 | 19.32 | 716,291 | 8.73 | 199.77% |
| 6 Months | 21.36 | 34.46 | 3.9501 | 14.55 | 7,243,377 | -8.26 | -38.67% |
| 1 Year | 708.00 | 1,130.40 | 3.9501 | 33.15 | 23,489,573 | -694.90 | -98.15% |
| 3 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,717,447 | -675.70 | -98.10% |
| 5 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,717,447 | -675.70 | -98.10% |
